Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS)

8.74 -0.05 (-0.57%) At close: 03:00PM CST

Lushang Freda Pharmaceutical Co.,Ltd.

No. 9777, Jingshi Road
Jinan
China

https://www.lshzy.com.cn

Sector(s): Real Estate
Industry: Real Estate - Development
Full Time Employees: 3,651

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Hongtao Wang	Accounting Supervisor	N/A	N/A	1976

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Lushang Freda Pharmaceutical Co.,Ltd. develops and operates real estate properties in China. The company offers property management services, such as non-owner value-added and community value-added services. It is also involved in medicine and health care; and real estate development and property management businesses. In addition, the company develops apartments, schools, hospitals, and public exhibition halls. Further, it is involved in cosmetics, raw materials, and additive businesses. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. Lushang Freda Pharmaceutical Co.,Ltd. was founded in 1993 and is headquartered in Jinan, China. The company is a subsidiary of Shandong Freda Biological Co., Ltd.

Corporate Governance

Lushang Freda Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.